Cholesterol homeostasis: A key to prevent or slow down neurodegeneration

Frontiers in Physiology

Volumn 3 JAN, Issue , 2013, Pages

  Anchisi, Laura ^a,b   Dessì, Sandra ^c   Pani, Alessandra ^c   Mandas, Antonella ^c  

^a Division of Nephrology and Dialysis   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cholesterol esterification; Cholesterol homeostasis; Drug targets; Neurodegenerative disorders; Neuronal membranes

Indexed keywords

ACYL COENZYME A DESATURASE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CAVEOLIN 1; CHLORPROMAZINE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MEPACRINE; PRION PROTEIN; PROGESTERONE; VERAPAMIL;

AUTISM; CENTRAL NERVOUS SYSTEM; CHOLESTEROL ESTERIFICATION; CHOLESTEROL HOMEOSTASIS; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; DRUG TARGETING; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; HOMEOSTASIS; HUMAN; LEARNING DISORDER; LIPID DEGRADATION; MOLECULAR INTERACTION; NERVE CELL MEMBRANE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 84874700285     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00486     Document Type: Review

References (101)

1. Abad-Rodriguez, J., Ledesma, M. D., Craessaerts, K., Perga, S., Medina, M., Delacourte, A., et al. (2004). Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167, 953-960.
2. Aittoniemi, J., Róg, T., Niemelä, P., Pasenkiewicz-Gierula, M., Karttunen, M., and Vattulainen, I. (2006). Tilt: major factor in sterols' ordering capability in membranes. J. Phys. Chem. B 110, 25562-25564.
3. Anchisi, L., Dessì, S., Pani, A., and Mandas, A. (2013). Neutral lipid determination in peripheral blood mononuclear cells: a useful tool for diagnostic and therapeutic interventions in dementia. J. Mol. Biomar. Diag. 3:1000136. http://dx.doi.org/10.4172/2155-9929.1000136
4. Anstey, K. J., Lipnicki, D. M., and Low, L. F. (2008). Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16, 343-354.
5. Asher, I. (2011). New perspectives in the care of Parkinson disease. Mo. Med. 109, 328-332.
6. Astarita, G., Jung, K. M., Vasilevko, V., Dipatr izio, N. V., Martin, S. K., Cribbs, D. H., et al. (2011). Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. PLoS ONE 6:e24777. doi: 10. 1371/journal. pone. 0024777
7. Babiker, A., and Diczfalusy, U. (1998). Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta 1392, 333-339.
8. Bari, M., Battista, N., Fezza, F., Finazzi-Agrò, A., and Maccarrone, M. (2005). Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J. Biol. Chem. 280, 12212-12220.
9. Bartzokis, G. (2004). Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25, 5-18.
10. Beel, A. J., Sakakura, M., Barrett, P. J., and Sanders, C. R. (2010). Direct binding of cholesterol to the amyloid precursor protein: an important interaction in lipid-Alzheimer's disease relationships? Biochim. Biophys. Acta 1801, 975-982.
11. Bhattacharyya, R., and Kovacs, D. M. (2010). ACAT inhibition and amyloid beta reduction. Biochim. Biophys. Acta 1801, 960-965.
12. Blüml, S., Wisnowski, J. L., Nelson, M. D. Jr., Paquette, L., Gilles, F. H., Kinney, H. C., et al. (2012). Metabolic maturation of the human brain from birth through adolescence: insights from in vivo magnetic resonance spectroscopy. Cereb. Cortex. doi: 10. 1093/cercor/bhs283. [Epub ahead of print].
13. Bocan, T. M., Mueller, S. B., Uhlendorf, P. D., Brown, E. Q., Mazur, M. J., and Black, A. E. (1993). Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig. Atherosclerosis 99, 175-186.
14. Brown, D. A., and London, E. (1998). Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136.
15. Bryleva, E. Y., Rogers, M. A., Chang, C. C., Buen, F., Harris, B. T., Rousselet, E., et al. (2010). ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc. Natl. Acad. Sci. U. S. A. 107, 3081-3086.
16. Butler, J. D., Blanchette-Mackie, J., Goldin, E., O'Neill, R. R., Carstea, G., Roff, C. F., et al. (1992). Progesterone blocks cholesterol translocation from lysosomes. J. Biol. Chem. 267, 23797-23805.
17. Cansell, M., Gouygou, J. P., Jozefonvicz, J., and Letourneur, D. (1997). Lipid composition of cultured endothelial cells in relation to their growth. Lipids 32, 39-44.
18. Chang, T. Y., Chang, C. C., Lin, S., Yu, C., Li, B. L., and Miyazaki, A. (2001). Roles of acyl-coenzyme A: cholesterol acyltransferase-1 and -2. Curr. Opin. Lipidol. 12, 289-296.
19. Chang, T. Y., Chang, C. C., Ohgami, N., and Yamauchi, Y. (2006). Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol. 22, 129-157.
20. Chang, T. Y., Li, B. L., Chang, C. C., and Urano, Y. (2009). Acyl-coenzyme A: cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 297, E1-E9.
21. Christie, W. W. (2008). "Sterols 1. Cholesterol and cholesterol esters: structure, occurrence, biochemistry and analysis, " in AOCS Lipid Library: Lipid Chemistry, Biology, Technology and Analysis (Dundee, Scotland). Available online at: http://lipidlibrary.aocs.org/
22. Cutler, R. G., Pedersen, W. A., Camandola, S., Rothstein, J. D., and Mattson, M. P. (2002). Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 52, 448-457.
23. Debry, P., Nash, E. A., Neklason, D. W., and Metherall, J. E. (1997). Role of multidrug resistance P-glycoproteins in cholesterol esterification. J. Biol. Chem. 272, 1026-1031.
24. Dietschy, J. M. (2009). Central nervous system: cholesterol turnover, brain development and neurodegeneration. J. Biol. Chem. 390, 287-293.
25. Dietschy, J. M., and Turley, S. D. (2004). Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375-1397.
26. Dohura, K., Iwaki, T., and Caughey, B. (2000). Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74, 4894-4897.
27. Ehnholm, C. (2009). Cellular Lipid Metabolism. Berlin; Heidelberg: Springer-Verlag.
28. Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., et al. (2008). Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat. Med. 14, 843-848.
29. Farese, R. V. Jr. (2006). The nine lives of ACAT inhibitors. Arterioscler. Thromb. Vasc. Biol. 26, 1684-1686.
30. Fernø, J., Skrede, S., Vik-Mo, A. O., Havic, B., and Steen, V. D. (2006). Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci. 7:69. doi: 10. 1186/1471-2202-7-69
31. George, K. S., and Wu, S. (2012). Lipid raft: a floating island of death or survival. Toxicol. Appl. Pharmacol. 259, 311-319.
32. Gomez-Ramos, P., and Asuncion Moran, M. (2007). Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains. J. Alzheimers Dis. 11, 53-59.
33. Hagerman, R. J. (2006). Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J. Dev. Behav. Pediatr. 27, 63-74.
34. Halloran, J., Hussong, S. A., Burbank, R., Podlutskaya, N., Fischer, K. E., Sloane, L. B., et al. (2012). Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behaviour throughoutlifespaninmice. Neuroscience 223, 102-113.
35. Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395.
36. Head, B. P., Peart, J. N., Panneerselvam, M., Yokoyama, T., Pearn, M. L., Niesman, I. R., et al. (2010). Loss of caveolin-1 accelerates neurodegeneration and aging. PLoS ONE 5:e15697. doi: 10. 1371/journal. pone. 0015697
37. Höglund, K., Wallin, A., and Blennow, K. (2006). Effect of statins on betaamyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease. Acta Neurol. Scand. Suppl. 185, 87-92.
38. Husuf, H. K. M. (1992). Understanding the Brain and its Development. Singapore: World Scientific Publication.
39. Hutter-Paier, B., Huttunen, H. J., Puglielli, L., Eckman, C. B., Kim, D. Y., Hofmeister, A., et al. (2004). The ACAT inhibitor CP-113, 818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44, 227-238.
40. Huttunen, H. J., Havas, D., Peach, C., Barren, C., Duller, S., Xia, W., et al. (2010). The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice. J. Neuropathol. Exp. Neurol. 69, 777-788.
41. Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J. H., Petritis, B., et al. (2009). A systems approach to prion disease. Mol. Syst. Biol. 5:252. doi: 10. 1038/msb. 2009. 10
42. Jiménez-López, J. M., Ríos-Marco, P., Marco, C., Segovia, J. L., and Carrasco, M. P. (2010). Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids. Lipids Health Dis. 9:33. doi: 10. 1186/1476-511X-9-33
43. Johnson, C. P., Myers, S. M., and American Academy of Pediatrics Council on Children With Disabilities. (2007). Identification and evaluation of children with autism spectrum disorders. Pediatrics 120, 1183-1215.
44. Johnson, M. H. (2001). Functional brain development in humans. Nat. Rev. Neurosci. 2, 475-483.
45. Kimoto, T., Tsurugizawa, T., Ohta, Y., Makino, J., Tamura, Ho., Hojo, Y., et al. (2006). Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 103, 14602-14607.
46. Klingenstein, R., Löber, S., Kujala, P., Godsave, S., Leliveld, S. R., Gmeiner, P., et al. (2006). Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J. Neurochem. 98, 748-759.
47. Korade, Z., and Kenworthy, A. K. (2008). Lipid rafts, cholesterol, and the brain. Neuropharmacology 55, 1265-1273.
48. Koudinov, A. R., and Koudinova, N. V. (2003). Cholesterol, synaptic function and Alzheimer's disease. Pharmacopsychiatry 36, S107-S112.
49. Kuhne, M., Schachar, R., and Tannock, R. (1997). Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36, 1715-1725.
50. Kusunoki, J., Hansoty, D. K., Aragane, K., Fallon, J. T., Badimon, J. J., and Fisher, E. A. (2001). Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 103, 2604-2609.
51. Ledesma, M. D., and Dotti, C. G. (2005). The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system. Biochem. Soc. Symp. 72, 129-138.
52. Ledesma, M. D., and Dotti, C. G. (2006). Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for? FEBS Lett. 580, 5525-5532.
53. Ledesma, M. D., and Dotti, C. G. (2012). Peripheral cholesterol, metabolic disorders and Alzheimer's disease. Front. Biosci. (Elite Ed. ) 4, 181-194.
54. Lee, R. W., and Tierney, E. (2011). Hypothesis: the role of sterols in autism spectrum disorder. Autism Res. Treat. 2011:653570. doi: 10. 1155/2011/653570
55. Luessi, F., Siffrin, V., and Zipp, F. (2012). Neurodegeneration in multiple sclerosis: novel treatment strategies. Expert. Rev. Neurother. 12, 1061-1077.
56. Machtoub, L., Bataveljic, D., and Andjus, P. R. (2011). Molecular imaging of brain lipid environment of lymphocytes in amyotrophic lateral sclerosis using magnetic resonance imaging and SECARS microscopy. Physiol. Res. 60, S121-S127.
57. Martin, M., Dotti, C. G., and Ledesma, M. D. (2010). Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta 1801, 934-944.
58. Martinez-Seara, H., Ro'g, T., Karttunen, M., Vattulainen, I., and Reigada, R. (2010). Cholesterol induces specific spatial and orientational order in cholesterol/phospholipid membranes. PLoS ONE 5:e11162. doi: 10. 1371/journal. pone. 0011162
59. Matsuzawa, J., Matsui, M., Konishi, T., Noguchi, K., Gur, R. C., Bilker, W., et al. (2001). Age-related volumetric changes of brain gray and white matter in healthy infants and children. Cereb. Cortex 11, 335-342.
60. Mellon, S. H., and Griffin, L. D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 13, 35-43.
61. Morell, P., and Jurevics, H. (1996). Origin of cholesterol in myelin. Neurochem. Res. 21, 463-470.
62. Mulas, M. F., Abete, C., Pulisci, D., Pani, A., Massidda, B., Dessì, S., et al. (2011). Cholesterol esters as growth regulators of lymphocytic leukaemia cells. Cell Prolif. 44, 360-371.
63. Murai, T. (2012). The role of lipid rafts in cancer cell adhesion and migration. Int. J. Cell. Biol. 6. Article ID: 763283. doi: 10. 1155/2012/763283
64. Nicolson, G. L., Gan, R., Nicolson, N. L., and Haier, J. (2007). Evidence for mycoplasma, chlamydia pneunomiae and HHV-6 Co-infections in the blood of patients with autism spectrum disorder. J. Neurosci. Res. 85, 1143-1148.
65. Orrù, C. D., Abete, C., Cannas, M. D., Mulas, C., Norfo, C., Mandas, A., et al. (2010a). ACAT-1, Cav-1 and PrP expression in scrapie susceptible and resistant sheep. Cen. Eur. J. Biol. 5, 31-37.
66. Orrù, C. D., Cannas, M. D., Vascellari, S., Angius, F., Cocco, P. L., Abete, C., et al. (2010b). In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine. Cen. Eur. J. Biol. 5, 151-165.
67. Orrù, C. D., Cannas, M. D., Vascellari, S., Abete, C., Angius, F., Cocco, P. L., et al. (2010c). Pharmacologicinduced cholesterol homeostasis affects prion generation in a synergistic manner. Open Conf. Proc. J. 1, 54-60.
68. Orth, M., and Bellosta, S. (2012). Cholesterol: its regulation and role in central nervous system disorders. Cholesterol 19. Article ID: 292598. doi: 10. 1155/2012/292598
69. Pani, A., and Dessì, S. (2003). Cell Growth and Cholesterol Esters. New York, NY: Kluwer Academic/Plenum Publisher.
70. Pani, A., Dessì, S., Diaz, G., La Colla, P., Abete, C., Mulas, C., et al. (2009a). Altered cholesterol ester cycle in skin fibroblasts from patients with Alzheimer's disease. J. Alzheimers Dis. 18, 829-841.
71. Pani, A., Mandas, A., Diaz, G., Abete, C., Cocco, P. L., Angius, F., et al. (2009b). Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease. BMC Med. 7:66. doi: 10. 1186/ 1741-7015-7-66
72. Pani, A., Mandas, A., and Dessì, S. (2011). Cholesterol, Alzheimer's disease, prion disorders: a menage atrois?Cur. Drug Targ. 11, 1018-1031.
73. Pani, A., Norfo, C., Abete, C., Mulas, C., Putzolu, M., Laconi, S., et al. (2007a). Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Antimicrob. Agents Chemother. 51, 4141-4147.
74. Pani, A., Norfo, C., Abete, C., Mulas, C., Putzolu, M., Laconi, S., et al. (2007b). Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines. Am. J. Infec. Dis. 3, 165-168.
75. Pani, A., Abete, C., Norfo, C., Mulas, C., Putzolu, M., Laconi, S., et al. (2007c). Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapieresistant and scrapie-susceptible genotypes. Am. J. Infec. Dis. 3, 143-150.
76. Paton, C. M., and Ntambi, J. M. (2009). Biochemical and physiological function of stearoyl-CoA desat-urase. Am. J. Physiol. Endocrinol. Metab. 297, E28-E37.
77. Paus, T., Collins, D. L., Evans, A. C., Leonard, G., Pike, B., and Zijdenbos, A. (2001). Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res. Bull. 54, 255-266.
78. Perrey, S., Legendre, C., Matsuura, A., Guffroy, C., Binet, J., Ohbayashi, S., et al. (2001). Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis 155, 359-370.
79. Pike, L. (2003). Lipid rafts bringing order to chaos. J. Lipid Res. 44, 655-667.
80. Posse de Chaves, E., and Narayanaswami, V. (2008). Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol. 3, 505-530.
81. Prasanthi, J. R., Huls, A., Thomasson, S., Thompson, A., Schommer, E., and Ghribi, O. (2009). Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol. Neurodegener. 4:1. doi: 10. 1186/1750-1326-4-1
82. Pratt, A. J., Getzoff, E. D., and Perry, J. J. (2012). Amyotrophic lateral sclerosis: update and new developments. Degener. Neurol. Neuromuscul. Dis. 2012, 1-14.
83. Puglielli, L., Konopka, G., Pack-Chung, E., Ingano, L. A., Berezovska, O., Hyman, B. T., et al. (2001). Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell. Biol. 3, 905-912.
84. Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M. C., et al. (2005). High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468-475.
85. Shafaati, M., Solomon, A., Kivipelto, M., Björkhem, I., and Leoni, V. (2007). Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. Neurosci. Lett. 425, 78-82.
86. Simons, K., and Ehehalt, R. (2002). Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110, 597-603.
87. Simons, K., and Ikonen, E. (1997). Functional rafts in cell membranes. Nature 387, 569-572.
88. Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., and Simons, K. (1998). Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460-6464.
89. Smart, E. J., Ying, Y. S., Donzell, W. C., and Anderson, R. G. W. (1996). A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271, 29427-29435.
90. Spencer, T., Biederman, J., and Wilens, T. (1999). Attentiondeficit/hyperactivity disorder and comorbidity. Pediatr. Clin. North Am. 46, 915-927.
91. Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., et al. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5:e9979. doi: 10. 1371/journal. pone. 0009979
92. Tabas, I. (2002). Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110, 905-911.
93. Takahashi, H., Arai, S., Tanaka-Taya, K., and Okabe, N. (2001). Autism and infection/immunization episodes in Japan. Jpn. J. Infect. Dis. 54, 78-79.
94. Takahashi, M., Murate, M., Fukuda, M., Sato, S. B., Ohta, A., and Kobayashi, T. (2007). Cholesterol controls lipid endocytosis through Rab11. Mol. Biol. Cell 18, 2667-2677.
95. Thompson, L. M. (2008). Neurodegeneration: a question of balance. Nature 452, 707-708.
96. Varghese, Z., Fernando, R., Moorhead, J. F., Powis, S. H., and Ruan, X. Z. (2005). Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts. Am. J. Physiol. Renal Physiol. 289, 43-48.
97. Vik-Mo, A. O., Fernø, J., Skrede, S., and Steen, V. M. (2009). Psychotropic drugs upregulate the expression of cholesterol transport proteins including ApoE in cultured human CNS-and liver cells. BMC Pharmacol. 9:10. doi: 10. 1186/1471-2210-9-10
98. Waschbusch, D. A., Pelham, W. E. Jr., Jennings, J. R., Greiner, A. R., Tarter, R. E., and Moss, H. B. (2002). Reactive aggression in boys with disruptive behavior disorders: behavior, physiology, and affect. J. Abnorm. Child Psychol. 30, 641-656.
99. Wilens, T. E., Biederman, J., Brown, S., Tanguay, S., Monuteaux, M. C., Blake, C., et al. (2002). Psychiatric comorbidity and functioning in clinically referred preschool children and schoolage youths with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 41, 262-268.
100. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G. G., and Siegel, G. (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57, 1439-1443.
101. Yusuf, H. K., Dickerson, J. W., Hey, E. N., and Waterlow, J. C. (1981). Cholesterol esters of the human brain during fetal and early postnatal development: content and fatty acid composition. J. Neurochem. 36, 707-714.